Le Lézard
Classified in: Health
Subjects: PDT, EXE, ANW

Government of Canada Releases Pan-Canadian Framework on Antimicrobial Resistance


Coordinating action to address a global health threat

OTTAWA, Sept. 5, 2017 /CNW/ - Antimicrobial resistance (AMR) is one of the most serious global health threats facing the world today. Existing antibiotics are becoming less effective at treating infections and the development of new drugs is not keeping pace. Unless action is taken, even common infections could become life-threatening and estimates indicate that by 2050, annual worldwide human deaths attributable to AMR could reach 10 million.

To combat this outlook, Canada is tackling AMR with a concerted and coordinated effort from all levels of government and across sectors, including public health, healthcare, animal health, agriculture, industry and academia.

The Honourable Ginette Petitpas Taylor, Minister of Health, and the Honourable Lawrence MacAulay, Minister of Agriculture and Agri-Food, today released Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action. The Pan-Canadian Framework was developed jointly with provinces and territories and other key partners in the human and animal health sectors to guide collective action in tackling AMR in Canada. The Framework identifies opportunities for action and desired outcomes under four pillars: surveillance, stewardship, infection prevention and control, and research and innovation. A Pan-Canadian Action Plan will be developed to define specific commitments, measurable outcomes, and timeframes to put the Framework into use.

The Pan-Canadian Framework builds on existing provincial, territorial and external stakeholder efforts on AMR. It also complements the Federal Action Plan on Antimicrobial Resistance and Use in Canada, released in March 2015, which laid out the concrete actions the Government of Canada is taking to address AMR.

Quotes

"Antimicrobial resistance is a serious global health threat that cannot be overlooked. Our Government is committed to taking action to mitigate the impact of antimicrobial resistance on Canadians. We are enhancing surveillance; promoting good infection prevention and control practices; promoting the responsible use of antimicrobials; and supporting research and innovation for new prevention and treatment products."

The Honourable Ginette Petitpas Taylor, P.C., M.P.
Minister of Health

"The prudent use of antimicrobials is an important issue involving not only human health, but the health of animals, food safety, environment and the economy. Agriculture must play an important role in containing the development and spread of antimicrobial resistance. Our government continues to work closely with its partners to improve practices relating to antimicrobial resistance." 

The Honourable Lawrence MacAulay, P.C., M.P.
Minister of Agriculture and Agri-Food

Quick Facts

Associated Links

Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action
Government of Canada takes action on antimicrobial resistance

Addressing global threat of antimicrobial resistance

 

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: